Repurposing alpha1 Noradrenergic Antagonists for Alcoholism Treatment

NCT02966340 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Alcoholism

Interventions

DRUG: Prazosin
DRUG: Placebo

Sponsor

University of Wisconsin, Madison

Collaborators

[object Object]